Australia is welcome a groundbreaking medication for excess weight: Retatrutide. The dual molecule – targeting on both GLP-1 and GIP receptors – shows remarkable outcomes in global studies, indicating meaningful decreases in weight. While regulatory clearance hasn't occurred with Australian regulators, several Australians struggling weight-rela